ANI Pharma (ANIP) Tops Q1 EPS by 25c, Revenues Beat; Reaffirms FY19 Revenue Outlook
Go back to ANI Pharma (ANIP) Tops Q1 EPS by 25c, Revenues Beat; Reaffirms FY19 Revenue Outlook| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 78.85 +2.71 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.14 | 52 Week High | $70.92 | |||
| Open | $75.50 | 52 Week Low | $26.80 | |||
| Day High | $79.43 | P/E | N/A | |||
| Day Low | $75.00 | EPS | $-0.96 | |||
| Volume | 579,335 | |||||
